Mechanistic studies in LPS-stimulated A549 cells and an ALI rat model demonstrated that SLEL exerted a dose-dependent inhibitory effect on the PI3K-Akt and MAPK-NF-κB signaling pathways. This evidence concerns the gene NFKB1 and acute respiratory distress syndrome.